{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:51Z","timestamp":1791235431472,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cld.2018.12.006","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T01:54:09Z","timestamp":1552010049000},"page":"233-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Endocrine Diseases and the Liver"],"prefix":"10.1016","volume":"23","author":[{"given":"Miguel","family":"Malespin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Nassri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.cld.2018.12.006_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF01239888","article-title":"The hypothalamus and liver metabolism","volume":"30","author":"Ban","year":"1967","journal-title":"Acta Neuroveg (Wien)"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ar.a.20086","article-title":"Neural connections between the hypothalamus and the liver","volume":"280","author":"Uyama","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"10.1016\/j.cld.2018.12.006_bib4","series-title":"Endotext","article-title":"Adrenal insufficiency","author":"Nicolaides","year":"2000"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib5","first-page":"1160","article-title":"Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans","volume":"76","author":"Zimmermann","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cld.2018.12.006_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-3002(60)91374-3","article-title":"6-Hydroxylation, the major metabolic pathway for melatonin","volume":"40","author":"Kopin","year":"1960","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.cld.2018.12.006_bib7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0024-3205(78)90583-0","article-title":"Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light\/dark cycle","volume":"23","author":"Lynch","year":"1978","journal-title":"Life Sci"},{"issue":"2\u20133","key":"10.1016\/j.cld.2018.12.006_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","article-title":"Melatonin: physiological effects in humans","volume":"61","author":"Claustrat","year":"2015","journal-title":"Neurochirurgie"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-079X.1997.tb00332.x","article-title":"Melatonin site and mechanism of action: single or multiple?","volume":"23","author":"Cardinali","year":"1997","journal-title":"J\u00a0Pineal Res"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib10","first-page":"251","article-title":"In\u00a0vivo protection against kainate-induced apoptosis by the pineal hormone melatonin: effect of exogenous melatonin and circadian rhythm","volume":"9","author":"Manev","year":"1996","journal-title":"Restor Neurol Neurosci"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-079X.2007.00450.x","article-title":"Pinealectomy reduces hepatic and muscular glycogen content and attenuates aerobic power adaptability in trained rats","volume":"43","author":"Borges-Silva","year":"2007","journal-title":"J\u00a0Pineal Res"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MEG.0b013e32835ab5dc","article-title":"Estrogen derivatives: novel therapeutic agents for liver cirrhosis and portal hypertension","volume":"25","author":"Zhang","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2018.12.006_bib13","series-title":"Endotext","article-title":"Metabolism of thyroid hormone","author":"Peeters","year":"2000"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib16","first-page":"232","article-title":"The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action","volume":"1","author":"Larsen","year":"2012","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(87)90260-5","article-title":"The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats","volume":"420","author":"Riskind","year":"1987","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.cld.2018.12.006_bib18","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1172\/JCI25083","article-title":"Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans","volume":"115","author":"Maia","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2018.12.006_bib19","first-page":"1","article-title":"Treatment for primary hypothyroidism: current approaches and future possibilities","volume":"6","author":"Chakera","year":"2012","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"10.1016\/j.cld.2018.12.006_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2006.0235","article-title":"Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)","volume":"17","author":"Aoki","year":"2007","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11102-008-0122-6","article-title":"Central hypothyroidism","volume":"11","author":"Lania","year":"2008","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2265.2003.01786.x","article-title":"Musculoskeletal manifestations in patients with thyroid disease","volume":"59","author":"Cakir","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.1711320105","article-title":"Hypothyroid myopathy. A clinical and pathologaical study","volume":"132","author":"McKeran","year":"1980","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0733-8619(05)70186-9","article-title":"Endocrine myopathies","volume":"18","author":"Horak","year":"2000","journal-title":"Neurol Clin"},{"key":"10.1016\/j.cld.2018.12.006_bib26","first-page":"569","article-title":"Myopathy presenting as a sole manifestation of hypothyroidism","volume":"58","author":"Madhu","year":"2010","journal-title":"J\u00a0Assoc Physicians India"},{"issue":"10","key":"10.1016\/j.cld.2018.12.006_bib27","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1210\/jcem.82.10.4296","article-title":"Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism","volume":"82","author":"Monzani","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"25","key":"10.1016\/j.cld.2018.12.006_bib28","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"issue":"19","key":"10.1016\/j.cld.2018.12.006_bib30","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","article-title":"Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner","volume":"285","author":"Adams","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","article-title":"Clinical associations between thyroid and liver diseases","volume":"10","author":"Huang","year":"1995","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.cld.2018.12.006_bib32","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.1984.03350170010007","article-title":"Hypothyroidism-associated cholestasis","volume":"252","author":"Ariza","year":"1984","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hep.1840090225","article-title":"Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono- and diconjugates in the Wistar rat","volume":"9","author":"Van Steenbergen","year":"1989","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/cen.13312","article-title":"Incidence of abnormal liver biochemical tests in hyperthyroidism","volume":"86","author":"Lin","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.cld.2018.12.006_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/milmed\/143.8.548","article-title":"Abnormalities of liver function tests in tyrotoxicosis","volume":"143","author":"Thompson","year":"1978","journal-title":"Mil Med"},{"issue":"8","key":"10.1016\/j.cld.2018.12.006_bib36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI102338","article-title":"A\u00a0correlative study of the cardiac output and the hepatic circulation in hyperthyroidism","volume":"29","author":"Myers","year":"1950","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0676.1991.tb00516.x","article-title":"Liver changes in patients with hyperthyroidism","volume":"11","author":"Sola","year":"1991","journal-title":"Liver"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00004836-199912000-00004","article-title":"Thyroid storm presenting with liver failure","volume":"29","author":"Choudhary","year":"1999","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib39","first-page":"1727","article-title":"Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?","volume":"82","author":"Williams","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1572-0241.2001.03469.x","article-title":"The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study","volume":"96","author":"Kim","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004836-199704000-00013","article-title":"Liver tests in hyperthyroidism: effect of antithyroid therapy","volume":"24","author":"Gurlek","year":"1997","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1590\/S0004-28032015000200009","article-title":"The influence of end-stage liver disease and liver transplantation on thyroid hormones","volume":"52","author":"Penteado","year":"2015","journal-title":"Arq Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2018.12.006_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.24.7.631","article-title":"Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism","volume":"24","author":"Borzio","year":"1983","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1977.tb01337.x","article-title":"Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities","volume":"7","author":"Green","year":"1977","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03349374","article-title":"Relations between serum levels of TSH, TBG, T4, T3, rT3 and various histologically classified chronic liver diseases","volume":"3","author":"L'Age","year":"1980","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib47","first-page":"83","article-title":"Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy","volume":"2","author":"Guven","year":"1993","journal-title":"Eur J Med"},{"issue":"13\u201314","key":"10.1016\/j.cld.2018.12.006_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4414\/smw.2003.10172","article-title":"Low serum total thyroxine and free triiodothyronine in patients with hepatic encephalopathy due to non-alcoholic cirrhosis","volume":"133","author":"Kayacetin","year":"2003","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib49","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF02774261","article-title":"Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3\/T3 ratio as prognostic indices","volume":"22","author":"Kano","year":"1987","journal-title":"Gastroenterol Jpn"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12020-009-9210-2","article-title":"Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences","volume":"36","author":"Kostopanagiotou","year":"2009","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib51","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0016-5085(19)30497-4","article-title":"Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome","volume":"78","author":"Crowe","year":"1980","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cld.2018.12.006_bib52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.cld.2018.12.006_bib54","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2018.12.006_bib55","doi-asserted-by":"crossref","first-page":"1423462","DOI":"10.1155\/2016\/1423462","article-title":"Diagnosis and management of cirrhosis-related osteoporosis","volume":"2016","author":"Santos","year":"2016","journal-title":"Biomed Res Int"},{"issue":"8","key":"10.1016\/j.cld.2018.12.006_bib56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2169\/internalmedicine.9490-17","article-title":"Glycogenic hepatopathy in type 1 diabetes mellitus","volume":"57","author":"Asada","year":"2018","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib57","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1900\/RDS.2011.8.454","article-title":"Hepatic steatosis in type 1 diabetes","volume":"8","author":"Regnell","year":"2011","journal-title":"Rev Diabet Stud"},{"issue":"11","key":"10.1016\/j.cld.2018.12.006_bib58","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes","volume":"19","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cld.2018.12.006_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"26","key":"10.1016\/j.cld.2018.12.006_bib61","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2018.12.006_bib62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"126","key":"10.1016\/j.cld.2018.12.006_bib63","first-page":"1289","article-title":"Estrogen-induced cholestasis: pathogenesis and therapeutic implications","volume":"60","author":"Chen","year":"2013","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0028-1085099","article-title":"Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy","volume":"28","author":"Perarnau","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","article-title":"Testosterone in men with advanced liver disease: abnormalities and implications","volume":"30","author":"Sinclair","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib66","first-page":"495","article-title":"Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis","volume":"15","author":"Zietz","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib67","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03346393","article-title":"Male hypogonadism in cirrhosis and after liver transplantation","volume":"31","author":"Foresta","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(94)80020-0","article-title":"Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease","volume":"20","author":"Guechot","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2018.12.006_bib69","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/lt.20812","article-title":"Sexual functioning in patients with end-stage liver disease before and after transplantation","volume":"12","author":"Sorrell","year":"2006","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1043-4666(05)80001-8","article-title":"Cytokines and hypothalamic-pituitary function","volume":"5","author":"Jones","year":"1993","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.cld.2018.12.006_bib71","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/lt.24607","article-title":"Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score","volume":"22","author":"Sinclair","year":"2016","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib72","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/0016-5085(95)90595-2","article-title":"Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values","volume":"109","author":"Boulton","year":"1995","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib73","first-page":"435","article-title":"Liver involvement in Addison's disease","volume":"85","author":"Olsson","year":"1990","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2018.12.006_bib74","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s10620-008-0297-8","article-title":"Addison\u2019s disease: a rare cause of hypertransaminasaemia","volume":"53","author":"Ersan","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.23736\/S0391-1977.16.02583-9","article-title":"Adrenal disorders and non-alcoholic fatty liver disease","volume":"42","author":"Papanastasiou","year":"2017","journal-title":"Minerva Endocrinol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib76","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1440-1827.2007.02112.x","article-title":"Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits","volume":"57","author":"Matsumoto","year":"2007","journal-title":"Pathol Int"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib77","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.51.243","article-title":"Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade","volume":"51","author":"Yamashita","year":"2004","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ajh.2009.206","article-title":"Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study","volume":"23","author":"Fallo","year":"2010","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.cld.2018.12.006_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis","volume":"183","author":"Chen","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"9","key":"10.1016\/j.cld.2018.12.006_bib81","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib82","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib83","first-page":"407","article-title":"Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats","volume":"26","author":"Noguchi","year":"2010","journal-title":"Int J Mol Med"},{"issue":"12","key":"10.1016\/j.cld.2018.12.006_bib84","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.metabol.2013.08.008","article-title":"A\u00a0meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients","volume":"62","author":"Yang","year":"2013","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.cld.2018.12.006_bib85","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib86","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/liv.12611","article-title":"Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease","volume":"35","author":"Goh","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3803\/EnM.2014.29.1.83","article-title":"Pheochromocytoma with markedly abnormal liver function tests and severe leukocytosis","volume":"29","author":"Eun","year":"2014","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"10.1016\/j.cld.2018.12.006_bib88","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.2003.026658","article-title":"Hepatic fibrogenesis requires sympathetic neurotransmitters","volume":"53","author":"Oben","year":"2004","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.cld.2018.12.006_bib89","doi-asserted-by":"crossref","first-page":"e72928","DOI":"10.1371\/journal.pone.0072928","article-title":"Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells","volume":"8","author":"Sigala","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2018.12.006_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3748\/wjg.v19.i4.445","article-title":"Update on adrenal insufficiency in patients with liver cirrhosis","volume":"19","author":"Trifan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2018.12.006_bib91","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.dld.2015.08.006","article-title":"Hypothalamus-pituitary dysfunction is common in patients with stable cirrhosis and abnormal low dose synacthen test","volume":"47","author":"Fede","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.cld.2018.12.006_bib92","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.dld.2018.05.011","article-title":"Relative adrenal insufficiency in cirrhotic patients with ascites (hepatoadrenal syndrome)","volume":"50","author":"Singh","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"26","key":"10.1016\/j.cld.2018.12.006_bib93","doi-asserted-by":"crossref","first-page":"e11046","DOI":"10.1097\/MD.0000000000011046","article-title":"Clinical characteristics and prevalence of adrenal insufficiency in hemodynamically stable patients with cirrhosis","volume":"97","author":"Park","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.cld.2018.12.006_bib94","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.cld.2018.12.006_bib95","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0024-3205(98)00077-0","article-title":"Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells","volume":"62","author":"Yaguchi","year":"1998","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib96","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.ATV.14.1.8","article-title":"Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells","volume":"14","author":"Ettinger","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"6","key":"10.1016\/j.cld.2018.12.006_bib97","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/IAI.70.6.2995-3003.2002","article-title":"Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells","volume":"70","author":"Baranova","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.cld.2018.12.006_bib98","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endo-127-1-101","article-title":"Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors","volume":"127","author":"Gaillard","year":"1990","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.cld.2018.12.006_bib99","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra020529","article-title":"Corticosteroid insufficiency in acutely ill patients","volume":"348","author":"Cooper","year":"2003","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:45Z","timestamp":1761069405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1089326118301107"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Diseases and the Liver","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}